Detalles de la búsqueda
1.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis).
J Eur Acad Dermatol Venereol
; 37(1): 93-103, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156312
2.
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Eur Acad Dermatol Venereol
; 37(5): 1017-1027, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695061
3.
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis).
Dermatol Ther
; 35(8): e15608, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638250
4.
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Acta Derm Venereol
; 101(3): adv00422, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269404
5.
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
Acta Derm Venereol
; 101(10): adv00576, 2021 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903916
6.
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study.
Dermatol Ther
; 33(6): e14044, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697028
7.
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation.
Rheumatol Immunol Res
; 5(1): 49-56, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38571927
8.
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting.
Dermatol Ther (Heidelb)
; 14(5): 1273-1291, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727995
9.
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis).
Dermatol Ther (Heidelb)
; 14(6): 1649-1657, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748344
10.
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort.
Int J Dermatol
; 63(3): 351-358, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38178802
11.
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Clin Med
; 13(2)2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38256629
12.
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).
J Dermatolog Treat
; 35(1): 2350760, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38714323
13.
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).
Dermatol Pract Concept
; 14(2)2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416060
14.
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study.
Clin Cosmet Investig Dermatol
; 16: 27-38, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636635
15.
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy.
J Dermatolog Treat
; 34(1): 2200868, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026590
16.
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus.
Dermatol Ther (Heidelb)
; 13(6): 1219-1241, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210684
17.
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
Front Immunol
; 14: 1341708, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38274801
18.
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis).
Front Med (Lausanne)
; 10: 1196966, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37469659
19.
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.
J Clin Med
; 12(10)2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240650
20.
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis).
Front Med (Lausanne)
; 10: 1243843, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614958